Reprogramming the immune system: mRNA lipoplex particles

Lukas Uebbing and Vera Cornet, pharmacists and Ph.D students at the Institute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Germany, discuss their research using liposomal formulations and the creation of mRNA lipoplex preparations to deliver mRNA to target cells, such as dendritic and T cells. To make modeling approaches easier, the researchers use high-purity Avanti lipids, and extrusion methodologies using the Avanti mini-extruder to prepare liposome nanoparticles. This research aims to gain a greater understanding of these particles as the basis of new therapeutic approaches to fight cancer.

Products in use:
Avanti® Mini-Extruder
http://ms.spr.ly/6059bbUJV

Avanti® Polar Lipids DOTMA
Avanti® Polar Lipids C16 PEG2000 Ceramide
Avanti® Polar Lipids 18:1 TAP (DOTAP)
http://ms.spr.ly/6050bbUJn